Oct 21, 2011, 06.48 PM IST | Source: Moneycontrol.com

Fresenius Kabi Sep '11 sales at Rs 159.26 crore

Fresenius Kabi Oncology has reported a sales turnover of Rs 159.26 crore and a net profit of Rs 45.40 crore for the quarter ended Sep '11

Fresenius Kabi Sep '11 sales at Rs 159.26 crore
Fresenius Kabi Oncology has reported a sales turnover of Rs 159.26 crore and a net profit of Rs 45.40 crore for the quarter ended Sep '11.
For the quarter ended Sep 2010 the sales turnover was Rs 104.68 crore and net profit was Rs 21.91 crore.
Quarterly Results of Fresenius Kabi Oncology-------- in Rs. Cr. --------
Sep '10Jun '11Sep '11
Sales Turnover104.68114.94159.26
Other Income0.840.420.43
Total Income105.52115.36159.69
Total Expenses68.3991.98140.53
Operating Profit36.2922.9618.73
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses----37.21
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit37.1323.3819.16
Interest4.645.391.92
PBDT32.4817.9954.45
Depreciation3.595.705.96
Depreciation On Revaluation Of Assets------
PBT28.8912.2948.49
Tax6.982.383.09
Net Profit21.919.9145.40
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share1.380.632.87
Book Value------
Equity15.8215.8215.82
Reserves------
Face Value1.001.001.00
Source : Dion Global Solutions Limited
Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Rahul Gandhi

576.23 -7.75 -1.33%

62344

Bought today

170682

Sold today

0.31%

User holding

video of the day

Chandra says satisfied with TCS' FY14, FY15 to be better

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.